Management Team
Dr. William R. Rassman, Chairman, CEO and Founder
Dr. William R. Rassman received his Doctor of Medicine from the Medical College of Virginia in 1966. He completed a surgical internship at the University of Minnesota and obtained a cardiovascular fellowship with Dr. C.W. Lillehei. Dr. Rassman completed his residency in general surgery at the Cornell Medical Center and Dartmouth Medical Center. He served as a Major in the U.S. Army, and was stationed as a surgeon in the Republic of Vietnam. Dr. Rassman was certified by the American Board of Surgery in 1976. Dr. Rassman was a major researcher in the cardiac field commercializing the Intra-Aortic Balloon Pump in 1969, a device credited with saving thousands of lives annually. As a professional inventor with multiple U.S. and worldwide patents, Dr. Rassman has 30 years of managerial and executive experience with numerous medical groups and various companies in the sciences through start-up and sale. In all fields he has pioneered new techniques, published articles in prestigious medical journals, presented scientific papers before national and international societies and continues to push the 'state-of-the-art' to new heights.
Dr. Shane C. Dultz, Chief Scientific Officer (CSO)
Dr. Dultz's research experience covers a broad range of fields over the last 15 years, having worked in three academic departments: Physics/Astronomy, Chemistry/Biochemistry, and Pathology/Laboratory Medicine, as well as high-tech companies in three different industries. His industrial R&D experience includes quantum information technology, quantum cryptography, medical devices, protein/DNA detection technologies, and optics. He has eight inventions, five of which are now pending patents related to the LFIRE technology. He was a Caltech postdoctoral scholar in the Superconducting and Magnetic Materials Group at Jet Propulsion Laboratory after receiving his Ph.D. in Condensed Matter Physics from the University of California, Los Angeles. Dr. Dultz establishes strategic direction for design and product development activities, is actively involved in all business development activities and contract negotiations.
David Ralin, Chief Technology Officer (CTO)
David Ralin is the technical leader of the Maven founding team, he developed Maven's technology from the earliest concept stage to a fully integrated prototype and currently focuses on applications development. Prior to Maven, David has twelve years experience in quality and manufacturing engineering for high-volume disposable consumer healthcare products and medical device product development. David has more experience than anyone else on the project team with assay development using the LFIRE technology. His expertise in protein microarrays, surface chemistry, sample handling and quality control of essential aspects of the system makes him the best-qualified user and developer of our technology. David's input is invaluable during the development process to ensure the instrument requirements remain consistent with end-user needs.
Jeffrey Chongsathien M.Eng. M.Sci. M.A.Cantab
Jeffrey Chongsathien has developed hardware control, image analysis, data handling and user interface software for our prototype instruments. He contributes substantially to the design and implementation of our commercial instruments and to our business activities. Jeffrey has a background in nanotechnology at both UCLA and the University of Cambridge, England, where he studied Physical Chemistry and Engineering respectively. He has worked for Sony Digital Media Europe in the digital television division, assisting in electronic circuit development and programming firmware for infra-red communications devices.
Board Members
Dr. Norman F. Estrin, Board of Trustees
Dr. Norman F. Estrin has also been on MavenŐs board since 2001. He is a recognized authority in the medical device and cosmetic industries with over 25 years of experience in directing scientific and technical programs in these industries. For the past decade, he has worked exclusively in FDA matters, consulting for a variety of pharmaceutical companies and medical device companies wishing to bring FDA regulated products to market. He has given workshops on how to do effective medical device submissions and has testified before a congressional committee on nitrosamine contamination of cosmetics.
Maureen A. O'Hara, Board of Trustees
Maureen A. O'Hara joined Maven Biotechnologies in 2001 while LFIRE was still in its infancy. Before Maven, she has worked in and around the technology field for over 25 years. Maureen's journey has included DOD contracting, work with start-ups, a seven year stint at Microsoft, a principle in her own management coaching LLC, and a faculty member at University of Washington. Maureen brings to Maven her understanding of managing start-ups and marketing, and the drive to see a product to fruition.
|
 |
